{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:53:03Z","timestamp":1788835983973,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese National Science and Technology","award":["H1609-81172102"],"award-info":[{"award-number":["H1609-81172102"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.07.071","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T14:00:16Z","timestamp":1406728816000},"page":"6820-6827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells"],"prefix":"10.1016","volume":"32","author":[{"given":"Kehua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Zhu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.071_bib0005","first-page":"97","article-title":"Human diploid cell strains (HDCS) viral vaccines","volume":"93","author":"Fletcher","year":"1998","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0092-1157(76)90018-4","article-title":"The status of human diploid cell strain MRC-5 as an approved substrate for the production of viral vaccines","volume":"4","author":"Jacobs","year":"1976","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/227168a0","article-title":"Characteristics of a human diploid cell designated MRC-5","volume":"227","author":"Jacobs","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0020","first-page":"255","article-title":"Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells","volume":"37","author":"Mann","year":"1976","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/jmv.21804","article-title":"Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate","volume":"83","author":"Alirezaie","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0030","first-page":"475","article-title":"Production of herpes simplex virus from MRC-5 cells grown in a glass bead culture system","volume":"60","author":"Thornton","year":"1985","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0035","first-page":"297","article-title":"Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines","volume":"37","author":"Mirchamsy","year":"1976","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0264-410X(93)90204-B","article-title":"Preparation and immunogenicity of an inactivated hepatitis A vaccine","volume":"11","author":"Pellegrini","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.11150\/kansenshogakuzasshi1970.76.432","article-title":"The usefulness of human lung embryonal fibroblast cells (MRC-5) for isolation of enteroviruses and adenoviruses","volume":"76","author":"Shinohara","year":"2002","journal-title":"Kansenshogaku zasshi"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1423-0410.2009.01227.x","article-title":"Mesenchymal stem cells for clinical application","volume":"98","author":"Sensebe","year":"2010","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0070","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0075","doi-asserted-by":"crossref","first-page":"R210","DOI":"10.1186\/ar3187","article-title":"Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis","volume":"12","author":"Liu","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","article-title":"Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases","volume":"10","author":"Uccelli","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12015-010-9196-4","article-title":"Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes","volume":"7","author":"Anzalone","year":"2011","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0090","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0095","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/stem.118","article-title":"Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression","volume":"27","author":"Ren","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0100","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI31178","article-title":"Indoleamine 2,3-dioxygenase and tumor-induced tolerance","volume":"117","author":"Munn","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00441-008-0696-3","article-title":"Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion","volume":"334","author":"Jo","year":"2008","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1365-2184.2008.00559.x","article-title":"Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow","volume":"41","author":"Choumerianou","year":"2008","journal-title":"Cell Prolif"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/CBI20110350","article-title":"Differentiation of human umbilical cord mesenchymal stem cells into hepatocyte-like cells by hTERT gene transfection in vitro","volume":"36","author":"Liang","year":"2012","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0120","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1158\/0008-5472.CAN-06-4690","article-title":"Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms","volume":"67","author":"Bernardo","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0125","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0409s84","article-title":"Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation","author":"Parish","year":"2009","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.2010.197","article-title":"Good manufacturing practices production of mesenchymal stem\/stromal cells","volume":"22","author":"Sensebe","year":"2011","journal-title":"Human Gene Ther"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3923\/ajb.2012.27.36","article-title":"The proliferation and differentiation capacity of bone marrow derived-human mesenchymal stem cells in early and late doubling","volume":"7","author":"Boroujeni","year":"2012","journal-title":"Asian J Biochem"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s10561-014-9420-6","article-title":"Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium","author":"Chen","year":"2014","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.vaccine.2014.07.071_bib0145","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jcyt.2013.05.024","article-title":"Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System","volume":"15","author":"Jones","year":"2013","journal-title":"Cytotherapy"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:23:20Z","timestamp":1538382200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14010238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":29,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14010238"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}